Piramal Pharma Limited reports a change in its board or management
In short
Piramal Pharma Limited informed the NSE on a change in directors, KMP, SMP, auditor or RTA. No figures, breakdowns or dates are given in the text. In simple terms, the company is reporting a change in its leadership or related key professional roles. No closing date or validity period is stated.
Why it matters
A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.